Aprea Therapeutics, Inc. (APRE)

Retained Earnings

-$340.52M

Quarterly · Period ending: · USD

APRE logo

APRE Retained Earnings

Latest reported-$340.52M
APRE Quarterly Retained Earnings (-$62.47M → -$340.52M)
High-resolution chart · PNG

APRE retained earnings history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Aprea Therapeutics, Inc. Retained Earnings — Quarterly (USD)
Period endingRetained Earnings (USD)
-340,520,662
-336,929,358
-333,641,441
-331,185,811
-328,213,401
-324,974,531
-321,041,872
-318,147,073
-314,363,304
-310,893,252
-308,083,161
-304,639,907
-301,435,392
-298,176,295
-293,796,405
-291,354,263
-287,329,545
-189,071,071
-181,134,378
-173,379,194
-163,926,843
-153,675,830
-144,007,075
-128,614,529
-116,296,447
-99,928,520
-90,528,263
-77,455,525
-71,206,106
-62,468,456
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.